跳至主要内容
临床试验/NCT00120211
NCT00120211已完成3 期

Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

International Atomic Energy Agency0 个研究点目标入组 855 人开始时间: 1998年9月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
855
主要终点
Three Years Loco-regional Control

研究概览

简要总结

This trial compares the use of 6 fractions versus the standard 5 fractions of radiotherapy used in the treatment of head and neck cancer.

详细描述

The purpose of this trial is to study the clinical effects of increasing the weekly fraction number for locally advanced head and neck cancers by a multi-institutional prospective randomised trial. The primary endpoint is to clarify whether a six fraction per week protocol has a greater effect on the survival, as compared to the conventional five fraction per week protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Head and Neck Cancer

排除标准

  • •Unable to give an informed consent

研究组 & 干预措施

Radiotherapy: 6 Fractions

Experimental

干预措施: Accelerated Radiotherapy Fractionation (Radiation)

Radiotherapy: 5 fractions

Active Comparator

干预措施: Accelerated Radiotherapy Fractionation (Radiation)

结局指标

主要结局

Three Years Loco-regional Control

时间窗: 3 years

次要结局

  • Disease-specific Survival(8 years)
  • Overall Survival(8 years)
  • Acute Adverse Effects
  • Late Adverse Effects(8 years)

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验